Get started
Author

Pierfrancesco Ruffo

Observed names: P Ruffo, P. Ruffo, Ruffo Pierfrancesco
OpenAlex ID: A5025619708
Depression: cost-of-illness studies in the international literature, a review
2000 · Patrizia Berto, Daniele D'Ilario, et al. · The Journal of Mental Health Policy and Economics · 191
Oncologist perspectives on chemotherapy‐induced nausea and vomiting (CINV) management and outcomes: A quantitative market research‐based survey
2018 · Matti Aapro, Pierfrancesco Ruffo, et al. · Cancer Reports · 50
PDF
Cost-of-illness study in acromegalic patients in Italy
2004 · G. Didoni, S. Grottoli, et al. · Journal of Endocrinological Investigation · 49
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries
2015 · Marco Turini, Vittoria Piovesana, et al. · Drugs in Context · 26
PDF
Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy
2005 · Mirko Di Martino, Luca Degli Esposti, et al. · European Journal of Clinical Pharmacology · 24
NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK
2017 · Helene Cawston, Francois Bourhis, et al. · Drugs in Context · 17
PDF
Cardiovascular risk in hypertensive patients: results of the Pandora project.
2002 · Roberto Cocchi, Ezio Degli Esposti, et al. · PubMed · 11
The PANDORA project: results of the cost of illness analysis
2001 · E Degli Esposti, P Berto, et al. · Journal of Human Hypertension · 10
The Pandora Project: Cost of Hypertension from a General Practitioner Database
2002 · Patrizia Berto, Ezio Degli Esposti, et al. · Blood Pressure · 8
PDF
Different aspects of adherence to antihypertensive treatments
2004 · Stefania Lopatriello, Patrizia Berto, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 7
Assessment of antihypertensive drug use in primary care in Ravenna, Italy, based on data collected in the PANDORA Project
2002 · Alessandra Sturani, Ezio Degli Esposti, et al. · Clinical Therapeutics · 7
Fixed Combination Netupitant And Palonosetron Is A Cost-Effective Intervention For The Prevention Of Chemotherapy-Induced Nausea And Vomiting In The Uk
2015 · P D’agostino, H Cawston, et al. · Value in Health · 5
Donepezil Italian global impact study (DIGIS)
2000 · Mauro Tettamanti, Daniela Casilli, et al. · Neurobiology of Aging · 3
Pcn174 - Nepa, an Oral Fixed Combination of Netupitant and Palonosetron, Is a Cost-effective Intervention for the Prevention of Chemotherapy-induced Nausea and Vomiting (cinv) in Germany and Greece
2018 · F. Bourhis, J. Eriksson, et al. · Value in Health · 2
[A cross-sectional survey to evaluate the cardiovascular risk profile in subjects referred to the Verona-ASL 20 general practitioners].
2005 · Desirée Bastarolo, Alessandro Battaggia, et al. · PubMed · 2
Identification of factors influencing chemotherapy-induced nausea and vomiting (CINV) treatment compliance – results from quantitative market research.
2016 · Pierfrancesco Ruffo, Roger Panteri, et al. · Journal of Clinical Oncology · 1
Pcv25 Economic Evaluation of Primary Prevention of Cvd Events With Atorvastatin:an Italian Perspective
2002 · LG Mantovani, P Ruffo, et al. · Value in Health · 1
Pcv7 Economic Evaluation of the Atorvastatin Versus Revascularization Treatment Study (avert):an Italian Customization
2002 · P Ruffo, S Campanella, et al. · Value in Health · 1
Valutazione dell'SF-12 come strumento di rilevazione dello stato di salute percepito in Italia Progetto - MIOS
2000 · N Groth, G Apolone, et al. · Use Siena air (University of Siena) · 1
Pcn249 - Chemotherapy-induced Nausea and Vomiting (cinv) and Drivers of Antiemetic Prescribing: Results of a Qualitative In-practice Study of Clinicians From Various Settings
2018 · T.W. LeBlanc, P. D'Agostino, et al. · Value in Health
化学療法誘発悪心および嘔吐(cinv)管理および転帰に関する腫瘍学者の展望:定量的市場研究に基づく調査【jst・京大機械翻訳】
2018 · Aapro Matti, Ruffo Pierfrancesco, et al. · Cancer Reports
Analisi costo-efficacia dell’associazione budesonide/formoterolo come terapia di mantenimento e “al bisogno” nella gestione dell’asma. Valutazione italiana
2009 · C. Lazzaro, P. Ruffo, et al. · PharmacoEconomics Italian Research Articles
Pcv60 Treatment of Newly-diagnosed Hypertensive Patients in Italya Retrospective Cohort Study in Primary Care
2004 · S Bustacchini, G Mazzaglia, et al. · Value in Health
PDF
Pcv36 Economic Evaluation of Primary Prevention of Cvd Events With Statins in Italy
2004 · S Bustacchini, P Ruffo, et al. · Value in Health
Persistence With Diuretics in Newly Treated Hypertensive Patients in Italy
2004 · G. Mazzaglia, A. P. Caputi, et al. · Journal of Hypertension
Works count: 32
Citation count: 416
H-index: 8
I10-index: 8
Year
Topic
Type